Effect of CO2 and QS ND YAG in treatment of melasma

The Effect of CO2 and QS Neodymium-Doped Yttrium Aluminium Garnet Lasers on the Treatment of Melasma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180402039170N1

Enrollment

Registered

2018-04-14

Start date

2017-08-23

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melasma. Chloasma

Interventions

Intervention group: patients with bilateral and symmetrical melasma who are treated simultaneously with both CO2 + QS ND YAG Lasers.

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 18-50 years old patients with symmetric and bilateral facial melasma

Exclusion criteria

Exclusion criteria: Female patients with pregnancy and lactation Patients with history of labial herpes infection Active infection and acne in treatment areas Patients with history of hypertrophic scar and keloid

Design outcomes

Primary

Measure	Time frame
Clearance of Melasma lesions according to Melasma Area and Severity Index scoring. Timepoint: Six months after treatment. Method of measurement: Melasma Area and Severity Index Score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShaghayegh hadadi

Ahvaz University of Medical Sciences

younesmbc2@yahoo.com+98 613332627

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026